Thursday, November 20, 2008 - 7:11PM EST

Clinical Trials

51. A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).

Author
Patel SH; Ajlouni M; Chapman R; Lu M; Movsas B; Kim JH;
Institution
Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan 48202, USA. spatel3@hfhs.org
Journal
J Thorac Oncol. 2007 Sep;2(9):831-7.
Abstract URL
Click here to view abstract

52. Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.

Author
Spigel DR; Hainsworth JD; Simons L; Meng C; Burris HA 3rd; Yardley DA; Grapski R; Schreeder M; Mallidi PV; Greco FA;
Institution
Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, Tennessee 37203, USA.
Journal
J Thorac Oncol. 2007 Sep;2(9):854-61.
Abstract URL
Click here to view abstract

53. Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.

Author
Heymach JV; Johnson BE; Prager D; Csada E; Roubec J; Pesek M; Spasova I; Belani CP; Bodrogi I; Gadgeel S; Kennedy SJ; Hou J; Herbst RS;
Institution
Dana-Farber Cancer Institute, Boston, MA, USA.
Journal
J Clin Oncol. 2007 Sep 20;25(27):4270-7.
Abstract URL
Click here to view abstract

54. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.

Author
Herbst RS; O'Neill VJ; Fehrenbacher L; Belani CP; Bonomi PD; Hart L; Melnyk O; Ramies D; Lin M; Sandler A;
Institution
The M.D. Anderson Cancer Center, Houston, TX 77030, USA. rherbst@mdanderson.org
Journal
J Clin Oncol. 2007 Oct 20;25(30):4743-50. Epub 2007 Oct 1.
Abstract URL
Click here to view abstract

55. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.

Author
Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L;
Institution
Division of Medical Oncology, Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada. vera.hirsh@muhc.mcgill.ca
Journal
J Thorac Oncol. 2007 Oct;2(10):927-32.
Abstract URL
Click here to view abstract

56. Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency.

Author
Mitsumori M; Zeng ZF; Oliynychenko P; Park JH; Choi IB; Tatsuzaki H; Tanaka Y; Hiraoka M;
Institution
Department of Therapeutic Radiology and Oncology, Kyoto University Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. mitsumo@kuhp.kyoto-u.ac.jp
Journal
Int J Clin Oncol. 2007 Jun;12(3):192-8. Epub 2007 Jun 27.
Abstract URL
Click here to view abstract

57. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.

Author
Temel JS; Jackson VA; Billings JA; Dahlin C; Block SD; Buss MK; Ostler P; Fidias P; Muzikansky A; Greer JA; Pirl WF; Lynch TJ;
Institution
Massachusetts General Hospital, Boston, MA 02114, USA. jtemel@partners.org
Journal
J Clin Oncol. 2007 Jun 10;25(17):2377-82.
Abstract URL
Click here to view abstract

58. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.

Author
Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y;
Institution
Department of Radiation Oncology, Shandong Cancer Hospital & Institute, Jinan, Shandong Province, China.
Journal
Am J Clin Oncol. 2007 Jun;30(3):239-44.
Abstract URL
Click here to view abstract

59. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.

Author
Lilenbaum R; Axelrod R; Thomas S; Dowlati A; Seigel L; Albert D; Witt K; Botkin D;
Institution
Mount Sinai Cancer Center; 4306 Alton Road; Miami Beach, FL 33140, USA. rlilenbaum@aptiumoncology.com
Journal
J Clin Oncol. 2008 Feb 20;26(6):863-9.
Abstract URL
Click here to view abstract

60. A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.

Author
Tabata M; Kozuki T; Ueoka H; Kiura K; Harita S; Tada A; Shibayama T; Takigawa N; Yonei T; Gemba K; Segawa Y; Kishino D; Tada S; Hiraki S; Tanimoto M;
Institution
Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
Journal
Cancer Chemother Pharmacol. 2007 Jun;60(1):53-9. Epub 2006 Sep 29.
Abstract URL
Click here to view abstract
Pages: 1 2 3 4 5 6 7 8 9 10 11 12